deltatrials
Unknown PHASE1/PHASE2 INTERVENTIONAL 3-arm NCT02943486

Mesenchymal Stromal Cell Derivatives in the Treatment of Chronic Diabetic Foot Ulcers Type 1 and 2 (MSCDTDFU)

Mesenchymal Stromal Cell Derivatives: a New Alternative and Potential Product for the Treatment of Diabetic Foot Ulcers 1 and 2

Sponsor: Fundación Oftalmológica de Santander Clínica Carlos Ardila Lulle

Updated 6 times since 2017 Last updated: Oct 21, 2016 Started: Jan 31, 2017 Primary completion: Jun 30, 2018 Completion: Jan 31, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1/PHASE2 trial investigates Foot Ulcer, Diabetic and is currently ongoing. Fundación Oftalmológica de Santander Clínica Carlos Ardila Lulle leads this study, which shows 6 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotNot Yet Recruiting~Jun 2018 – ~Feb 2019 · 8 months · monthly snapshotNot Yet Recruiting~Feb 2019 – ~Jan 2021 · 23 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 24 months · monthly snapshotUnknown

Change History

6 versions recorded
  1. Sep 2024 — Present [monthly]

    Unknown PHASE1/PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE1/PHASE2

    Status: Unknown StatusUnknown · Phase: PHASE1_PHASE2PHASE1/PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE1_PHASE2

  4. Feb 2019 — Jan 2021 [monthly]

    Unknown Status PHASE1_PHASE2

    Status: Not Yet RecruitingUnknown Status

  5. Jun 2018 — Feb 2019 [monthly]

    Not Yet Recruiting PHASE1_PHASE2

Show 1 earlier version
  1. Jan 2017 — Jun 2018 [monthly]

    Not Yet Recruiting PHASE1_PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Fundación Oftalmológica de Santander Clínica Carlos Ardila Lulle
  • Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnología (COLCIENCIAS)
  • Universidad Autónoma de Bucaramanga
Data source: Universidad Autónoma de Bucaramanga

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.